ORYZON GENOMICS, S.A. 09/12/2019 15:45 ORYZON GENOMICS, S.A. R&D: new licenses, patents and registered trademarks Oryzon presents new positive efficacy data of iadademstat from the Phase IIa ALICE trial in AML Número de registro: 284280